Table 4. Baseline prevalence of health conditions among HCS participants .
Conditions | N (%) | ||
Male (prevalence) | Female (prevalence) | Total | |
Diabetes | 883 (21.9) | 1343 (22.4) | 2226 (22.2) |
High blood pressure | 943 (23.4) | 1700 (28.4) | 2643 (26.4) |
Metabolic Syndrome | 1180 (29.3) | 2733 (45.7) | 3913 (39.1) |
Cardiac Ischemic | 447 (11.1) | 913 (15.3) | 1360 (13.6) |
MI History | 88 (2.2) | 97 (1. 6) | 185 (1.85) |
Stroke History | 70 (1.7) | 89 (1.5) | 159 (1.6) |
Renal Failure | 53 (1.3) | 70 (1.2) | 123 (1.2) |
Fatty Liver | 222 (5.5) | 453 (7.6) | 675 (6.7) |
Chronic Lung Disease | 211 (5.2) | 374 (6.3) | 585 (5.8) |
Thyroid disorders | 80 (2) | 460 (7.7) | 540 (5.4) |
Kidney Stone | 976 (24.2) | 901 (15.1) | 1877 (18.8) |
Gallstone | 55 (1.4) | 242 (4) | 297 (3.0) |
Rheumatic Disease | 62 (1.53) | 375 (6.3) | 437 (4.4) |
Chronic Headaches | 170 (4.2) | 580 (9.7) | 750 (7.5) |
Gestational Hypertension History | 0 (0.00) | 336 )5.6( | 336 )5.6( |
Gestational Diabetes History | 0 (0.00) | 221 ) 3.7( | 221 (3.7( |